Process for preparing inhibitors of nucleoside metabolism
View Patent ↗A process of preparing a compound of the formula (I) wherein B is chosen from OH, NH 2 , NHR, H or halogen; D is chosen from OH, NH 2 , NHR, H halogen or SCH 3 ; R is an optionally substituted alkyl, aralkyl or aryl group; and Z is selected from OH, hydrogen, halogen, hydroxy, SQ or OQ, Q is an optionally substituted alkyl, aralkyl or aryl group; or a tautomer thereof; or a pharmaceutically acceptable salt thereof; or an ester thereof; or a prodrug thereof, which comprises reacting a compound of the formula (II) with an anion produced by abstraction of the bromine or iodine atom from a compound of formula (XIX), to form a compound of formula (XX) The compound of formula (XX) is N- and O-deprotected to obtain the compound of formula (I).
1. A process of preparing the compound 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one, comprising the step of reacting a reagent capable of delivering a formyl equivalent with a compound of the formula (A)
wherein Y is an unsubstituted or substituted alkyl or arylalkyl group having 1 to 8 carbon atoms.
2. The process as claimed in claim 1 wherein the reagent capable of delivering a formyl equivalent is formamidine acetate.
3. The process as claimed in claim 1 wherein the compound of formula A is the compound 3-amino-2-ethoxycarbonylpyrrole.
4. A process of preparing the compound 3H,5H-pyrrolo [3, 2-d]pyrimidin-4-one, comprising the following steps:
(a) reacting isoxazole with alkoxide ions in the presence of an alcohol;
(b) quenching the reaction with an acid;
(c) reacting the resulting reaction mixture with a dialkyl aminomalonate;
(d) isolating an organic phase of the resulting reaction mixture and reducing it to a residue;
(e) reacting the residue from the organic phase with a base in a protic or aprotic solvent to produce a compound of formula (A)
wherein Y is an unsubstituted or substituted alkyl or arylalkyl group having 1 to 8 carbon atoms; and
(f) reacting the compound of formula (A) with a reagent capable of delivering a formyl equivalent.